Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising effects. However, the price of this innovative drug and its access have become key issues for patients and healthcare professionals. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant challenge to ma